Latest Kaiser Health News Stories
Trump Administration Moves To Make Health Care Costs More Transparent
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.
Genetic-Testing Scam Targets Seniors And Rips Off Medicare
Capitalizing on the growing popularity of genetic testing — and fears of terminal illness — scammers are persuading seniors to hand over cheek swabs with their DNA, not knowing it may lead to identity theft and Medicare fraud.
In A Messy Democratic Presidential Debate, Facts About ‘Medicare For All’ Get Tossed About
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
Democrats Favor Building On ACA Over ‘Medicare For All’
Asked to choose between building on the Affordable Care Act and replacing it with a national Medicare for All plan, 55% of Democrats and Democratic-leaning independents said they would expand the existing law, according to a Kaiser Family Foundation poll released Tuesday.
Klobuchar Says D.C. Has Enough Drug Lobbyists To Double-Team Lawmakers
The drug industry has the biggest lobbying war chest.
GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
KHN’s ‘What The Health?’: Cue The Drug Price Debate
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.
Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
Federal Suit Alleges ‘Staggering’ Urine Drug Testing Fraud At Tennessee Pain Clinics
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
Dream Of Retiring Abroad? The Reality: Medicare Doesn’t Travel Well
More than 400,000 U.S. workers have retired in foreign countries and their ranks are rising. But Medicare doesn’t cover most expenses overseas, so these expats will need to confront the cost of finding alternative insurance.
Missouri Firm With Silicon Valley Ties Faces Medicare Billing Scrutiny
Amid an overall crackdown on private insurers’ Medicare billing practices, a new government audit and a whistleblower suit allege St. Louis-based Essence Group Holdings Corp.’s Medicare Advantage plans overcharged taxpayers.
A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant
Banking on new cost estimates, a bipartisan coalition in Congress is poised to try — once again — to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.
Insurers Running Medicare Advantage Plans Overbill Taxpayers By Billions As Feds Struggle To Stop It
An enhanced government effort to catch insurers that overcharge Medicare faces resistance from the insurance industry.
KHN’s ‘What The Health?’: Could The ACA Really Go Away?
Is the entire Affordable Care Act unconstitutional? That was the question before a federal appeals court in New Orleans this week. Two of the three judges on the panel seemed inclined to agree with a lower court that the elimination of the tax penalty for failure to maintain coverage could mean the entire health law should fall. Also this week, President Donald Trump wants to improve care for people with kidney disease. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus courts blocking efforts to require drug prices in TV ads and to kick Planned Parenthood out of the federal family planning program. Plus, Rovner interviews University of Michigan law professor Nicholas Bagley about the latest legal threat to the ACA.
Using Obamacare Authority, Trump Aims To Shift Dialysis Care To Patients’ Homes
Only about 12% of dialysis patients get their treatment at home and the initiative aims to dramatically increase that number and move patients out of costly dialysis centers. It would also add provisions to boost the annual number of kidneys available for transplants.
Medicare Going In ‘Right Direction’ On Opioid Epidemic
A new report by the inspector general for HHS shows prescriptions to treat opioid addiction are way up in recent years, while prescriptions for the painkillers have fallen.
How To Get A Cheaper Prescription Before Leaving The Doctor’s Office
A pricing tool embedded in their electronic health record and prescribing system lets doctors see how much patients will pay out-of-pocket based on their insurance and the pharmacy. But doctors have been slow to adopt the technology, which has limitations.
KHN’s ‘What The Health?’: All About ‘Medicare for All’
Need to know more about “Medicare for All?” It’s a top issue in the Democratic presidential primary campaign. This holiday week, we are rerunning our explainer on the subject. But first, KHN’s “What the Health?” host Julie Rovner talks to KHN’s Shefali Luthra about how health played out in the first Democratic candidate debates last week.
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
Health Care Gets Heated On Night 2 Of The Democratic Presidential Debate
Though the candidates tended to agree on the end goal of universal coverage, differences emerged over how to get there.
